Drug treatment programs as sites of opportunity for the delivery of hepatitis C prevention education: Client and staff perspectives

Journal of Drug Issues

Volumn 34, Issue 4, 2004, Pages 861-878

  Munoz Plaza, Corrine E ^a,b   Strauss, Shiela M ^b,c   Astone, Janetta M ^b,d   Des Jarlais, Don C ^d,e,f   Hagan, Holly ^d,g  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b STOP HEP C Project   (United States)

^c Ctr for Drug Use HIV Res

^d NDRI

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATTITUDE; CLINICAL ARTICLE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEPATITIS C; HUMAN; MALE; MEDICAL STAFF; NORMAL HUMAN; PREVENTIVE HEALTH SERVICE; QUALITATIVE ANALYSIS; REVIEW; STAFF TRAINING;

EID: 11144342306     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260403400407     Document Type: Review

References (22)

1. Alter, M.J., & Moyer, L.A. 1998 The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 18(Suppl 1), S6-S10.
2. Astone, J., Strauss, S.M., Vassilev, Z.P., & Des Jarlais, D.C. 2003 Provision of hepatitis C education in a nationwide sample of drug treatment programs. Drug Education, 33(1), 107-117.
3. Centers for Disease Control and Prevention 1998 Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR-19), 1-39.
4. Chitwood, D.D., McBride, D.C., French, M.T., & Comerford, M. 1999 Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users and nonusers. Substance Use and Misuse, 34(4&5), 727-746.
5. Contoreggi, C., Rexroad, V.E., & Lange, W.R. 1998 Current management of infectious complications in the injecting drug user. Journal of Substance Abuse Treatment, 15(2), 95-106.
6. D'Aunno, T., Vaughn, T., & McElroy, P. 1999 An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40(June), 175-192.
7. Des Jarlais, D. 1990 Stages in the response of the drug abuse treatment system to the AIDS Epidemic in New York City. The Journal of Drug Issues, 20(2), 335-347.
8. Des Jarlais, D., & Schuchat, A. 2001 Hepatitis C among drug users: déjà vu all over again? American Journal of Public Health, 91(1), 21-22.
9. Dhopesh, V.P., Taylor, K.R., & Burke, W.M. 2000 Survey of hepatitis B and C in addiction treatment unit. American Journal of Drug and Alcohol Abuse, 26(4), 703-707.
10. Edlin, B.R. 2002 Prevention and Treatment of Hepatitis C in Injection Drug Users. Hepatology, 36(5)(Suppl 1), S210-S219.
11. Garfein, R.S., Vlahov, D., Galai, N., Doherty, M.C., & Nelson, K.E. 1996 Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5), 655-661.
12. Hagan, H., Thiede, H., Weiss, H.S., Hopkins, S.G., Duchin, J.S., & Alexander, E.R. 2001 Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42-46.
13. Patton, M.Q. 1990 Qualitative evaluation and research methods. Newbury Park: Sage Publications.
14. Pugatch, D., Levesque, B., Greene, S., Strong, L., Flanigan, T., & Lally, M. 2001 HIV Testing in the setting of inpatient acute substance abuse treatment. American Journal of Drug and Alcohol Abuse, 27(3), 491-499.
15. Seeff, L.B. 1999 Natural history of hepatitis C. American Journal of Medicine, 107(6B), 10-15.
16. Selwyn, P.A., Budner, N.S., Wasserman, W.C., & Arno, P.S. 1993 Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports, 108(4), 492-500.
17. Sorenson, J. 1991 Preventing HIV transmission in drug treatment programs: what works? Journal of Addictive Diseases, 10(4), 67-79.
18. Sorenson, J., Masson, C., & Perlman, D. 2002 HIV/Hepatitis prevention in drug abuse treatment programs: guidance from research. Science & Practice Perspectives, (July), 4-11.
19. Stein, M.D., Maksad, J., & Clarke, J. 2001 Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211-215.
20. Strauss, S.M., Falkin, G.P., Vassilev, Z., Des Jarlais, D., & Astone, J. 2002 A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment, 22, 55-62.
21. Strauss, S.M., Astone, J., Vassilev, Z.P., Des Jarlais, D., & Hagan, H. 2003 Gaps in the drug-free and methadone treatment program response to Hepatitis C. Journal of Substance Abuse Treatment, 24, 291-297.
22. Thomas, D.L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K.E. 1995 Correlates of hepatitis C virus infections among injection drug users. Medicine, 74(4), 212-220.